Molecular Beacon Probe definition

Molecular Beacon Probe means a detector probe with interacting label moieties covered by any claim of PHRI Patent Rights. A Molecular Beacon Probe may be free-floating or immobilized on a solid support. A Molecular Beacon Probe may generate a signal either by binding directly to a nucleic acid target or to a target-dependent nucleic acid sequence that is generated subsequent to and is dependent upon the binding of a protein or a nucleic acid directly to a macromolecular target. Molecular Beacon Probe excludes probes that must, in order that a signal be generated, interact with a macromolecule other than a nucleic acid target or a target-dependent nucleic acid sequence, when the probe is hybridized to a nucleic acid target or to a target-dependent nucleic acid sequence.
Molecular Beacon Probe means a free-floating detector probe with interacting label moieties covered by any claim of PHRI Patent Rights, provided such probe does not include a nucleic acid sequence that must, in order that a signal be generated, interact with a macromolecule other than the target when the probe is hybridized to target.
Molecular Beacon Probe means a detector probe with interacting label moieties covered by any claim of PHRI Patent Rights. A Molecular Beacon Probe [*]. A Molecular Beacon Probe may generate a signal either by binding directly to a nucleic acid target or [*]. Molecular Beacon Probe excludes probes that must, in order that a signal be generated, interact with a macromolecule other than a nucleic acid target or a target-dependent nucleic acid sequence, when the probe is hybridized to a nucleic acid target or to a target-dependent nucleic acid sequence.

Examples of Molecular Beacon Probe in a sentence

  • Further, rights under the Molecular Switch Patents are limited to inclusion or use of Molecular Beacon Probes, and no rights are granted under the Molecular Switch Patents for Kits or Assays that infringe those patents by reason of including or using a molecule that is not a Molecular Beacon Probe.

  • Jenie and Sismindari, "Optimization of Gold Nanoparticles and Molecular Beacon Probe for DNA Detection by Colorimetric Method," in Proceedings of the 4th International Conference on Sustainable Innovation 2020–Health Science and Nursing (ICoSIHSN 2020), 2021.


More Definitions of Molecular Beacon Probe

Molecular Beacon Probe means a detector probe with interacting label moieties covered by any claim of PHRI Patent Rights. A Molecular Beacon Probe [***]. A Molecular Beacon Probe may generate a signal either by binding directly to a nucleic acid target or [***

Related to Molecular Beacon Probe

  • Medical cannabis pharmacy means the same as that term is defined in Section 26-61a-102.

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Modular building manufacturer means a person or corporation who owns or operates a

  • Radiologic technologist means an individual, other than a licensed doctor of medicine, osteopathy,

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Radiologic technologist, limited means an individual, other than a licensed radiologic technologist,

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Iatrogenic infertility means an impairment of fertility by surgery, radiation, chemotherapy, or other medical treatment affecting reproductive organs or processes.

  • MPS means the Brooks Macdonald Managed Portfolio Service described in section 8.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • DS Electric generation service that is provided at retail pursuant to the Applicable Legal Authorities under the Company’s retail electric tariffs and under any other agreements or arrangements between the Company and Customers, to any Customer that is not being served by an EGS. Default Allocation Assessment – shall have the meaning ascribed to it under the PJM Agreements. Delivery Period – The delivery period specified in an Appendix C Transaction Confirmation. Delivery Point – Means the applicable zone of the Company as designated by PJM. DS Customer(s) – Retail customers who are provided Default Service pursuant to the terms of this Agreement, the Applicable Legal Authorities and the Company’s retail tariffs.

  • Autism spectrum disorders means any of the pervasive developmental disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, published by the American Psychiatric Association, including autistic disorder, Asperger's disorder and pervasive developmental disorder not otherwise specified.

  • Clean coal technology demonstration project means a project using funds appropriated under the heading “Department of Energy—Clean Coal Technology,” up to a total amount of $2,500,000,000 for commercial demonstration of clean coal technology, or similar projects funded through appropriations for the Environmental Protection Agency. The federal contribution for a qualifying project shall be at least 20 percent of the total cost of the demonstration project.

  • Clinical health service means a single diagnostic, therapeutic, rehabilitative, preventive or palliative

  • Pre-Licensed Therapist means an individual who has obtained a Master’s Degree in Social Work or Marriage and Family Therapy and is registered with the BBS as an Associate CSW or MFT Intern acquiring hours for licensing. An individual’s registration is subject to regulations adopted by the BBS.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • GCP means the Good Clinical Practices officially published by EMA, FDA and the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) that may be in effect from time to time and are applicable to the testing of the Compounds.

  • Drug store means a place whose principal business is, the

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • Biomarker means a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a specific therapeutic intervention. Biomarkers include, but are not limited to, gene mutations or protein expression.

  • Co-licensed partner means a person who, with at least one other person, has the right to engage in